| Literature DB >> 25250309 |
Joo-In Park1, Hae-Rahn Bae2, Chang Gun Kim3, Valentin A Stonik4, Jong-Young Kwak3.
Abstract
Many marine triterpene glycosides have in vitro and in vivo activities with very lowEntities:
Keywords: anticancer activity; cucumarioside; frondoside A; membrane transporters; stichoposides; triterpene glycosides
Year: 2014 PMID: 25250309 PMCID: PMC4159031 DOI: 10.3389/fchem.2014.00077
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
Figure 1Structures of STC (1) and STD(2).
Figure 2Structures of frondoside A (3) and cucumariosides (4-6).
Figure 3Structures of aglycone skeleton systems with 9(11) double bond (7), 9β-H-7(8)-unsaturation (8) and 3β, 20S-Dihydroxy-5α-lanostano-18(20)-lactone (9).
Figure 4Structures of plant triterpene glycosides.
Membrane transporters as potential targets of triterpene glycosides from sea cucumbers and plants.
| Pump | Na+-K+-ATPase | Glycyrrhizin Glycyrrhetinic acid | Itoh et al., | ||
| Psolusosides A and B | Gorshkova et al., | ||||
| Ca2+-ATPase in sarcoplasmic reticulum | Cyclopiazonic acid | Uyama et al., | |||
| Astragaloside IV | Xu et al., | ||||
| Multidrug-resistance protein-1 | Saikosaponin-d | Wong et al., | |||
| Ginsenoside Rp1 | Yun et al., | ||||
| Glycyrrhizin | Fu et al., | ||||
| Cucumarioside A2-2 | Menchinskaya et al., | ||||
| Frondoside A | Menchinskaya et al., | ||||
| Na+-Ca2+ exchange | Echinoside-A and –B | Yamasaki et al., | |||
| Channel | Voltage-gated | Voltage-gated Na+ channel | Ginsenoside Rg3 | Lee et al., | |
| Ginsenoside Rb1 | Xu and Huang, | ||||
| Ginsenoside Rg3 | Lee et al., | ||||
| Calcium-activated K+channel | Dehydrosoyasaponin I | McManus et al., | |||
| Ginsenoside Rg3 | Choi et al., | ||||
| Human ether-a-go-go related gene K+ channel | Ginsenoside Rg3 | Choi et al., | |||
| L-type voltage-gated calcium channel | Ginsenoside Rb1 | Lin et al., | |||
| Ligand-gated | Nicotinic acetylcholine receptor | Ginsenoside Rg3 | Lee et al., | ||
| N-methyl-D-aspartate receptor | Ginsenoside Rh2 | Lee et al., | |||
| Ginsenoside Rg3 | Kim et al., | ||||
| GABAA receptor | Ginsenoside Rg3 | Lee et al., | |||
| Ryanodine receptor | Ginsenoside Re | Wang et al., | |||
| Mechanosensitive | Transient receptor potential canonical | 20-O-β-d-Glucopyranosyl-20(S)-protopanaxadiol | Hwang et al., | ||
| Others | Auqaporin-1 | Ginsenoside Rg3 | Pan et al., | ||
| Auqaporin-4 | Astragaloside IV | Li et al., | |||
| Carrier | Glucose transporter (GLUT1, GLUT4) | Ginsenoside Rb1 | Shang et al., |
Sea cucumbers.
Figure 5Structures of 18(20)-lactone in the aglycone with oxygen group.
Figure 6Structures of STA (15) and STE (16).
Figure 7Structure of compound with (17) or without (18) a sulfate group at C-4 of the xylose residue.
Figure 8Structure of cucumarioside H.
Potential molecular mechanisms for anticancer activity of marine triterpene glycosides.
| Frondoside A | Inhibition of proliferation | Increased expression of p21 | 4 μg/mL (AsPC-1 cells) | Li et al., | |
| Induction of apoptosis | Caspase-independent pathway, mitochondrial pathway, increased expression of p53 | 1 μM (HL-60 cells) | Jin et al., | ||
| 2. 5 μM (MDA-MB 231 cells) | |||||
| Decreased expression of Bcl-1 and Mcl-1, increased expression of Bax | 4 μg/mL (AsPC-1 cells) | Al Marzouqui et al., 2011 | |||
| Antimetastatic activity | Inhibition of MMP-9 activation | 1 μM (MDA-MB-231 cells) | Li et al., | ||
| Inhibition of prostaglandin receptors EP4 and EP2 | 0.5 μM (Line 66.1 cells) | Park et al., | |||
| Ma et al., | |||||
| Stichoposide C | Induction of apoptosis | Extrinsic and intrinsic pathway, activation of acid SMase and neutral SMase, ceramide generation | 0.3 μM (HL-60 cells) | Yun et al., | |
| 0.5 μM (K562 cells) | |||||
| Stichoposide D | Induction of apoptosis | Extrinsic and intrinsic pathway, activation of ceramide synthase 6, ceramide generation | 1.5 μM (HL-60 cells) | Park et al., | |
| 1.0 μM (K562 cells) | Yun, | ||||
| Cucumaioside A2-2, A4-2 | Induction of apoptosis | Caspase-dependent pathway | 3 μM (HL-60 cells) | Jin et al., | |
| Echinoside A | Induction of apoptosis | Inhibition of the noncovalent binding of topoisomerase 2α to DNA | 2.4 μM (human cancer cell lines) | Li et al., | |
| Cell cycle arrest | Increased expression of | 2.7 μM (HepG2 cells) | Zhao et al., | ||
| Ds-echinoside A | Antimetastatic activity | Inhibition of NF-κB dependent MMP-9 and VEGF expression | 2.7 μM (HepG2 cells) | Zhao et al., | |
| Philinopside A | Induction of apoptosis | Inhibition of receptor tyrosine kinase autophosphorylation | 1.5−2.4 μM (Sarcoma 180, BEL-7402, MCF-7 cells) | Tong et al., | |
| Philinopside E | Antimetastatic activity | Inhibition of VEGFR2 signaling | ~4 μM | Tian et al., | |
| Inhibition of interaction between KDR and αvβ3 integrin | 2.5 μM | Tian et al., |
Figure 9Structures of EA (20) and DSEA (21).
Figure 10Structures of PA (22) and PE (23).